GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
Last trade$3.20
Day change-$0.10 (-3.03%)
Day range$2.38 – $3.60
Volume290,696
Market cap$29M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$29.33M
Price / earnings
—
Price / book
2.91×
Price / sales
182.95×
EV / sales
184.8×
EV / EBITDA
-2.81×
Profitability
Earnings per share
-$2.34
Return on assets
-56.28%
Return on equity
-206.64%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.17×
Current ratio
0.16×
Quick ratio
0.16×
Cash ratio
0.1×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$8.12M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for GRDX, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Revenue
$85.88K
$38.21K
$36.25K
Cost of revenue
$122.39K
$651.95K
$693.68K
Gross profit
-$36.51K
-$613.74K
-$657.43K
Selling, general and administrative
$2.99M
$2.37M
$3.14M
Research and development
$8.42K
$631.38K
$893.4K
Total operating expenses
$13.07M
$3M
$4.03M
Operating income
-$13.11M
-$3.61M
-$4.69M
Interest expense
-$387.44K
$0
-$490.84K
Income before taxes
-$13.1M
-$3.74M
-$4.05M
Income taxes
-$55.46K
-$297.63K
-$398.74K
Net income
-$13.04M
-$3.44M
-$3.14M
Net income attributable to common shareholders
-$12.9M
-$3.63M
-$3.07M
EBITDA
-$1.89M
-$3.61M
-$4.11M
Basic earnings per share
-$2.01
-$0.82
—
Diluted earnings per share
-$2.01
-$0.82
—
Recent news
Company coverage with links to the original publishers.
GridAI Technologies (Nasdaq: GRDX) announced a definitive agreement to acquire Pronghorn Resources, a Wyoming-based natural gas producer with ~100 MMcf/day production and 450+ miles of owned pipelines. The acquisition establishes a vertically integrated energy and AI infrastructure platform targeting 300 MW initial power delivery in 2027 to support hyperscale data center development. GridAI also acquired exclusive Wyoming rights for 1st American Nuclear Co.'s EAGL-1 240 MWe SMR platform.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.